Evidence map›Paper›PMID 34405450›Full record

ArticleJournal of clinical laboratory analysis2021

The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis.

Ting Chen, Jia-Ling Wei, Ting Leng, Fei Gao, Shun-Yu Hou

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Endometriosis: Challenges in Clinical Molecular Diagnostics and Treatment.International journal of molecular sciences · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inflammatory Markers in Women with Infertility: A Cross-Sectional Study.International journal of general medicine · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ting ChenThe Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Jia-Ling WeiThe Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Ting LengThe Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Fei GaoThe Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.ORCID https://orcid.org/0000-0002-1806-602X
Shun-Yu HouThe Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Suzhou Municipal Hospital · CN

Funding

the Science and Technology development Project of Suzhou SYS2020173the Science and Technology Project of Suzhou Kjxw2018026
6 · The paper itself

Abstract

backgroundWe aimed to analyze the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people, and establish a more efficient combined diagnostic model.

methodsWe retrospectively analyzed the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people. Binary logistic regression analysis was used to establish a combined diagnostic model. We plotted the receiver operator characteristic (ROC) curve to analyze the diagnostic efficiency of different diagnostic indexes.

resultsCompared with patients in the control group, patients in the endometriosis group had significantly lower eosinophil% (p = 0.045), neutrophil (p = 0.001), lymphocyte (p < 0.001), red blood cells (RBCs) (p < 0.001), and hemoglobin (HGB) (p < 0.001), and had significantly higher monocyte% (p = 0.008), monocyte-to-lymphocyte ratio (MLR) (p = 0.001), platelet-to-lymphocyte ratio (PLR) (p < 0.001), carbohydrate antigen (CA)-199 (p < 0.001), CA125 (p < 0.001), human epididymis protein (HE)-4 (p < 0.001), and the risk of ovarian malignancy algorithm (ROMA) (p < 0.001). The combined diagnostic model of HGB, CA199, CA125, and HE4 was established by binary logistic regression analysis. The ROC curve showed that the combined diagnostic model reached a sensitivity of 85.4%, a specificity of 78.83%, and an area under the curve of 0.900, which was significantly higher than that of the individual index in endometriosis diagnosis.

conclusionThe combined diagnostic model of HGB, CA199, CA125, and HE4 may provide a new approach for the early non-invasive diagnosis of endometriosis.

Indexed as

AlgorithmsAdultAntigens, Tumor-Associated, CarbohydrateBiomarkersBlood PlateletsCA-125 AntigenCase-Control StudiesEndometriosisFemaleHemoglobinsHumansLymphocytesMembrane ProteinsRetrospective StudiesROC CurveWAP Four-Disulfide Core Domain Protein 2Antigens, Tumor-Associated, CarbohydrateBiomarkersCA-125 Antigencarbohydrate antigen 199, humanHemoglobinsMembrane ProteinsMUC16 protein, humanWAP Four-Disulfide Core Domain Protein 2WFDC2 protein, humanCA125CA199endometriosisHE4HGB

Identifiers

PMID34405450
PMCPMC8418510
OpenAlexW3194969437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.